Considering the PARP-1 inhibiting effects of the abovementioned compounds (flavonoids and caffeine metabolites), there is a possibility that PARP-1 activity may directly or indirectly influence the pro-inflammatory cytokine production in COPD. This evidence concerns the gene PARP1 and chronic obstructive pulmonary disease.